Stay updated on HER2/EGFR Mutant Tumors Clinical Trial

Sign up to get notified when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2/EGFR Mutant Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.3, was added to the study's history, replacing the previous v3.5.2. This updates the record history to reflect an additional iteration of the record.
    Difference
    0.0%
    Check dated 2026-04-30T02:43:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Updated the site revision indicator from **v3.5.0** to **v3.5.2**.
    Difference
    0.0%
    Check dated 2026-04-22T17:58:00.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-25T00:35:40.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    A new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-10T14:36:22.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page history, replacing the previous v3.4.1; this is a minor maintenance update that does not affect study data or core content (To avoid being alerted by small changes, set an alert condition by clicking below).
    Difference
    0.0%
    Check dated 2026-02-17T00:54:19.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added Revision: v3.4.1. Removed the funding-lapse notice and the prior Revision: v3.4.0 reference.
    Difference
    0.4%
    Check dated 2026-02-09T20:20:32.000Z thumbnail image

Stay in the know with updates to HER2/EGFR Mutant Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2/EGFR Mutant Tumors Clinical Trial page.